CytoDyn Inc. (CYDY)
OTCMKTS · Delayed Price · Currency is USD
0.2390
-0.0110 (-4.40%)
Feb 9, 2026, 3:59 PM EST

CytoDyn Ratios and Metrics

Millions USD. Fiscal year is Jun - May.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Feb '26 May '25 May '24 May '23 May '22 May '21
3054271572392311,188
Market Cap Growth
13.36%172.64%-34.59%3.83%-80.59%-22.02%
Enterprise Value
3274381862712661,213
Last Close Price
0.240.340.160.260.321.90
PE Ratio
-188.79----
PS Ratio
----867.10-
PB Ratio
-2.54-4.45-1.34-2.19-2.44-56.52
EV/Sales Ratio
----998.20-
EV/EBITDA Ratio
-45.25----
EV/EBIT Ratio
-45.33----
Debt / Equity Ratio
-0.23-0.28-0.26-0.32-0.39-3.02
Debt / EBITDA Ratio
-2.80----
Asset Turnover
----0.00-
Quick Ratio
0.060.200.040.020.030.22
Current Ratio
0.100.250.130.090.090.24
Return on Assets (ROA)
-70.67%41.38%-100.64%-125.31%-112.71%-64.72%
Return on Capital Employed (ROCE)
25.10%-18.40%24.70%37.40%154.70%462.00%
Earnings Yield
-13.25%0.88%-31.82%-33.33%-91.40%-14.85%
FCF Yield
--2.05%-7.01%-10.48%-33.70%-9.91%
Buyback Yield / Dilution
-14.45%-28.20%-15.90%-23.58%-15.20%-39.54%
Updated Nov 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.